Peer Exchange

Strategies in Managing Cold Agglutinin Disease

September 24th 2021

A discussion on the management of cold agglutinin disease, and the impact of emerging therapies in the pipeline on payer and clinician considerations.

Reducing Alzheimer’s Disease Burden Through Early Diagnosis and Treatment

August 30th 2021

A panel of experts highlight the burden of Alzheimer’s disease and current unmet needs related to diagnosis and treatment, discuss clinical and payer considerations for the diagnosis and management of AD, and generate discussion around future directions in the diagnosis and treatment.

Population Health Implications of Cardiorenal Metabolic Syndrome

August 11th 2021

Neil Minkoff, MD; Nihar R. Desai, MD, MPH; Jeffrey Turner, MD; and Om P. Ganda, MD, explore opportunities for improving population health outcomes in cardiorenal metabolic syndrome, including clinical and payer considerations of emerging diabetes treatments.

Pre-Exposure Prophylaxis (PrEP) for HIV: Improving Access and Uptake

June 30th 2021

Neil Minkoff, MD; Ian Frank, MD; Ryan Bitton, PharmD, MBA; Jeffrey Crowley, MPH; and Carl Schmid, MBA explore the current landscape of HIV prevention with PrEP and discuss overcoming barriers to its use.

Reducing Disease Burden Through Early Diagnosis and Treatment of Spinal Muscular Atrophy (SMA)

April 20th 2021

Dennis P. Scanlon, PhD; Emma Ciafaloni, MD; Maria Lopes, MD, MS; Kevin U. Stephens, Sr, JD, MD; and Mary Schroth, MD, FAAP, FCCP provide an overview of the disease burden in spinal muscular atrophy and give insight into clinical and payor perspectives on screening and diagnosis, current treatment options, and new disease-modifying therapies in SMA.

Exploring the Implementation of Quality Care Programs for Patients with Myeloproliferative Neoplasms

February 24th 2021

Bruce Feinberg, DO; Kathy Oubre, Michael Reff, RPh, MBA; Jamile M. Shammo, MD; and Ruben Mesa, MD, discuss the incorporation of quality care programs for improved disease management and patient care for MPNs.

Emerging Treatment Options in Relapsed Refractory Multiple Myeloma

January 27th 2021

A panel of experts discuss existing treatment options for relapsed/refractory multiple myeloma and provide practical considerations for regimen selection and emerging treatment options.

Acute and Preventive Therapy for Migraine

January 20th 2021

Key opinion leaders discuss the differences between acute and preventive treatment in migraine, clinical guidelines and treatment selections, and options for migraine management and prevention.

Implications of Expanding Use of CAR T-Cell Therapy in Relapsed/Refractory Non-Hodgkin Lymphoma (NHL)

December 11th 2020

A discussion on the clinical impact of chimeric antigen receptor (CAR) T-cell therapy in relapsed/refractor (R/R) non-Hodgkin lymphoma and the role of expanding CAR T administration into the community practice setting.

Supporting Cross-Benefit Management of Infused Drugs

October 12th 2020

Optimizing the clinical and financial aspects of disease management when covering an infused drug product under the pharmacy and medical benefit.